Fibronectin is a stress responsive gene regulated by HSF1 in response to geldanamycin
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibronectin is a stress responsive gene regulated by HSF1 in response to geldanamycin
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-11
DOI
10.1038/s41598-017-18061-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mammalian Heat Shock Response and Mechanisms Underlying Its Genome-wide Transcriptional Regulation
- (2016) Dig B. Mahat et al. MOLECULAR CELL
- High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer
- (2016) Wenzhong Yi et al. ONCOLOGY REPORTS
- Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration
- (2015) Giorgia Pallocca et al. ARCHIVES OF TOXICOLOGY
- Glucose regulates heat shock factor 1 transcription activity via mTOR pathway in HCC cell lines
- (2015) Wanli Ma et al. CELL BIOLOGY INTERNATIONAL
- Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis
- (2015) Ayumi Iwasaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of fibronectin deposition improves experimental liver fibrosis
- (2015) Eva Altrock et al. JOURNAL OF HEPATOLOGY
- Circulating Fibronectin Controls Tumor Growth
- (2015) Anja von Au et al. NEOPLASIA
- The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
- (2014) Ruth Scherz-Shouval et al. CELL
- High Glucose Forces a Positive Feedback Loop Connecting Akt Kinase and FoxO1 Transcription Factor to Activate mTORC1 Kinase for Mesangial Cell Hypertrophy and Matrix Protein Expression
- (2014) Falguni Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of citrullinated cellular fibronectin in synovial fluid from patients with rheumatoid arthritis
- (2014) Eri Kimura et al. Modern Rheumatology
- A community computational challenge to predict the activity of pairs of compounds
- (2014) Mukesh Bansal et al. NATURE BIOTECHNOLOGY
- Hsp90 Binds Directly to Fibronectin (FN) and Inhibition Reduces the Extracellular Fibronectin Matrix in Breast Cancer Cells
- (2014) Morgan C. Hunter et al. PLoS One
- SDF-1α reduces fibronectin expression in rat mesangial cells induced by TGF-β1 and high glucose through PI3K/Akt pathway
- (2013) Dan Zhang et al. EXPERIMENTAL CELL RESEARCH
- Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State
- (2013) S. Santagata et al. SCIENCE
- Heat shock protein 90 (HSP90) inhibitors activate the heat shock factor 1 (HSF1) stress response pathway and improve glucose regulation in diabetic mice
- (2012) Jee-Hyung Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
- (2012) Mikko Taipale et al. CELL
- HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers
- (2012) Marc L. Mendillo et al. CELL
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
- (2012) L. Neckers et al. CLINICAL CANCER RESEARCH
- S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition
- (2012) Weihua Liu et al. EXPERIMENTAL CELL RESEARCH
- mTOR Is Essential for the Proteotoxic Stress Response, HSF1 Activation and Heat Shock Protein Synthesis
- (2012) Shiuh-Dih Chou et al. PLoS One
- Regulation of HSF1 Function in the Heat Stress Response: Implications in Aging and Disease
- (2011) Julius Anckar et al. Annual Review of Biochemistry
- HSP90 as a platform for the assembly of more effective cancer chemotherapy
- (2011) Luke Whitesell et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Quality control and fate determination of Hsp90 client proteins
- (2011) Maria A. Theodoraki et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo
- (2011) Feng Fang et al. CANCER
- Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
- (2011) Peter Friedl et al. CELL
- A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors
- (2011) Simon Pacey et al. CLINICAL CANCER RESEARCH
- Essential roles of fibronectin in the development of the left–right embryonic body plan
- (2011) Maria V. Pulina et al. DEVELOPMENTAL BIOLOGY
- Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
- (2011) Mina J Bissell et al. NATURE MEDICINE
- Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
- (2011) Richard J. Perrin et al. PLoS One
- Extracellular Matrix Degradation and Remodeling in Development and Disease
- (2011) P. Lu et al. Cold Spring Harbor Perspectives in Biology
- Upregulation of fibronectin expression by COX-2 is mediated by interaction with ELMO1
- (2010) Chen Yang et al. CELLULAR SIGNALLING
- KRIBB11 Inhibits HSP70 Synthesis through Inhibition of Heat Shock Factor 1 Function by Impairing the Recruitment of Positive Transcription Elongation Factor b to thehsp70Promoter
- (2010) Young Ju Yoon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy
- (2010) Nirmalya Dey et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
- (2009) Shivaani Kummar et al. EUROPEAN JOURNAL OF CANCER
- Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program
- (2008) Malcolm A. Smith et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started